July 20 will be discharged the last group of volunteers who have experienced a vaccine against coronavirus. Told about it in interview to the newspaper “Red star” head of the 48th Central research Institute of NBC defense forces of the armed forces medical service Colonel Sergey Borisevich. He added that the study participants detected the antibodies and the components of the drug is safe and well tolerated by man.
Borisevich said that the goal with those obtained in the test data, compiling final reports, presentation of results and the state registration of the vaccine product.
Vaccine COVID-19 was created on the same platform as the drug against Ebola and middle East respiratory syndrome. According to the Borisevich, after the vaccine immunity of the person will be able long to cope with the coronavirus.
Recall that the vaccine was produced in cooperation of the Ministry of defense of Russia and National research center of epidemiology and Microbiology them. N. F. Gamalei. The clinical trial participants were divided into two groups: the first received a single dose of the drug, and the second – enhanced vaccine, the so-called “booster” option. July 15, some of the volunteers were discharged.
Previously, “Profile” wrote that Russian vaccine against coronavirus will be available for civilian use since mid-July. Until 12 August, the health Ministry will carry out an inspection of completed batches.
